MedTrace Logo

Hepatitis B Virus Reactivation in COVID-19

NCT07154212 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1793

Last updated 2025-09-04

No results posted yet for this study

Summary

The aim of this observational cohort study was to evaluate adherence to hepatitis B virus (HBV) screening guidelines in a country characterized by low HBV prevalence and assess the potential reactivation and progression of HBV infection in anti-HBV core antigen antibodies (anti-HBc) positive patients receiving corticosteroids for coronavirus disease 2019 (COVID-19).

Conditions

Interventions

DIAGNOSTIC_TEST

Hepatitis B virus infection

anti-hepatitis B virus core antigen positive serologic status

Sponsors & Collaborators

  • University Medical Centre Ljubljana

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2022-04-08
Completion
2022-04-08

Countries

  • Slovenia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07154212 on ClinicalTrials.gov